Persch 1Mg/Ml Syrup 30Ml
Brand : barrett hodgson pakistan
How it works
The mechanism of action of risperidone in schizophrenia is unclear. The drug’s therapeutic activity in schizophrenia could be mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism. The clinical effect from risperidone results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone (paliperidone). Antagonism at receptors other than D2 and 5HT2 may explain some of the other effects of risperidone.
PERSCH ORAL SOLN 1 MG 30 ML
Requires Prescription (YES/NO)
It (risperidone) is indicated for the treatment of schizophrenia.
• Increased mortality in elderly patients with dementia-related psychosis • Cerebrovascular adverse events, including stroke, in elderly patients with dementia-related psychosis • Neuroleptic malignant syndrome • Tardive dyskinesia • Metabolic Changes (Hyperglycemia and diabetes mellitus, Dyslipidemia, and Weight Gain) • Hyperprolactinemia • Orthostatic hypotension • Falls • Leukopenia, neutropenia, and agranulocytosis • Potential for cognitive and motor impairment • Seizures • Dysphagia • Priapism • Disruption of body temperature regulation • Patients with Phenylketonuria .
When not to Use
It is contraindicated in patients with a known hypersensitivity to either risperidone or paliperidone, or to any of the excipients in the formulation. Hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients treated with risperidone and in patients treated with paliperidone. Paliperidone is a metabolite of risperidone.
Schizophrenia: Adults - Over 15yr , day one , 1mg twice daily , day two , 2mg twice daily , day three 3mg twice daily . Max 8mg twice daily. Elderly : Initially 0.5mg twice daily increasing in 0.5mg increments to 1-2mg twice daily. Always consult your doctor or pharmacist for dose adjustment.
Storage yes or /no
Store this medicine at room temperature, away from direct light and heat.
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
Neuroleptic Malignant Syndrome (NMS), a potentially fatal symptom complex, has been reported in association with antipsychotic drugs.
Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements, may develop in patients treated with antipsychotic drugs.
Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular/cerebrovascular risk. These metabolic changes include hyperglycemia, dyslipidemia, and body weight gain. While all of the drugs in the class have been shown to produce some metabolic changes, each drug has its own specific risk profile .
Always consult your physician before using any medicine.
Fluoxetine , Paroxetine , Carbamazepine , Ranitidine , Cimetidine , Erythromycin , Amitriptyline , levodopa , ketoconazole , verapamil , furoseamide , paliperidone , dopamine agonists , rifampicin , anticholinergics.
syr bd 1cc insulin 6mm syringe 1s
disprin 300mg dispersible tablets 100s (pack size 10 x 10s)
panadol 500mg tablets 200s ( pack size 20x10s)